Hannes Buelow
John Foxe
John Greally
walkley
  •  
  •  
  •  
  •  

Rose F. Kennedy Intellectual and Developmental Disabilities Research Center

Overview

Founded more than 40 years ago, the Rose F. Kennedy Intellectual and Developmental Disabilities Research Center (RFK IDDRC) has long been at the forefront of research on brain development and function, while providing clinical care for children with intellectual and developmental disabilities (IDDs).

  • The RFK IDDRC is also one of the oldest designated University Centers for Excellence in Developmental Disabilities Research, Education and Service (UCEDD), and as such, has intimate links to Einstein’s UCEDD clinical arm – the Children's Evaluation and Rehabilitation Center (CERC).
  • CERC provides clinicians and investigators with the challenge and opportunity of working with large numbers of IDD-related conditions in the genetically diverse and socioeconomically compromised population of the Bronx.
  • Demonstrating further integration within Einstein’s RFK IDDRC, the UCEDD is also home to the Leadership Education in Neurodevelopmental Disabilities (LEND) Program, one of only 38 in the United States, which supports interdisciplinary clinical training for medical and allied health professionals who care for individuals with special healthcare needs.
  • The RFK IDDRC is one of only a handful of centers in the nation with connections to all three of these important programs, and together they represent the hub of Einstein’s IDD research labs and patient clinics.
  • With access to state-of-the-art equipment and techniques, RFK IDDRC scientists are leading the way in research on autism, Rett, Fragile X, Niemann-Pick C and other genetic and neurometabolic disorders, bringing bench research discoveries to the bedside in the form of new and innovative therapies.

 

Highlights

  • On Wednesday, May 28, 2014 at the Albert Einstein College of Medicine's Annual Commencement Exercises, two IDDRC members were given special recognition:  Dr. Hannes Buelow, Ph.D., received the LaDonne H. Schulman Award for Excellence in Teaching and Dr. Steven U. Walkley, D.V.M., Ph.D. (IDDRC Director) received the Saul R. Korey Award in Translational Science and Medicine.
  • On Monday, March 24, 2014, Michelle W. Antoine, Ph.D., working out of IDDRC Member Dr. Jean M. Hébert's lab received a Marmur Award for her work on the “Impacts of inner ear dysfunction on brain activity and behavior.”

more highlights 


 

Related News & Features

read more

Research Round-Up

Elective ServiceDr. Susan Band Horwitz was elected to serve as one of the members of the AACR Nominating Committee for the 2012 to 2014 term. Founded in 1907, the AACR (American Association for Cancer Research), is the world’s first and largest professional organization dedicated to advancing cancer research and its mission to prevent and cure cancer. Its membership includes 34,000 laboratory, translational and clinical researchers; population scientists; other health care professionals; and cancer advocates residing in more than 90 countries. Dr. Horwitz is distinguished university professor and co-chair of molecular pharmacology at Einstein, as well as associate director for therapeutics for the Albert Einstein Cancer Center and the Rose C. Falkenstein Professor of Cancer Research. She also is an AACR past president and currently serves as a member on the Council of Scientific Advisors.

Good Reading Dr. U. Thomas Meier was awarded a $1.2 million grant over four years by the National Institute of General Medical Sciences to study how cells assemble small nucleolar RNA-protein complexes that function in the modification of ribosomal and other RNAs, thereby fine-tuning protein synthesis and pre-messenger RNA processing.  Dr. Meier’s laboratory will use novel approaches to shed light on these basic cellular processes, thus providing the foundation for understanding what goes wrong in certain genetic diseases and cancers.  Dr. Meier is professor of anatomy and structural biology.

read more

A Message From the Director

Dr Steven Walkley

Steven U. Walkley, D.V.M., Ph.D.


Most intellectual and developmental disabilities, particularly those with genetic causes, not only predominantly affect children but are also rare—as defined by the Rare Disease Act of 2002, they affect about 1 in 1,500 people. There are estimated to be almost 7,000 rare diseases, most of read more... 

 
 
 
 
 
 

In the Media

The Washington Post interviews Dr. John Foxe about his research with children who have difficulty processing sensory information, like sound and touch. (Tuesday, May 13, 2014)

MSNBC interviews Dr. John Foxe about the new CDC report that finds the rate of autism is now 1 in 68 U.S. children, up 30% from 1 in 88 in 2008. (Monday, Mar 31, 2014)

media coverage on other stories

Click here to log in